Impact of COVID-19-associated Mucormycosis in Kidney Transplant Recipients: A Multicenter Cohort Study.
Background. COVID-19-associated mucormycosis (CAM) is a recently emerging entity. There is a lack of reports of CAM in organ transplant recipients. Methods. We conducted a multicenter (n = 18) retrospective research in India during November 2020 to July 2021. The purpose of this study was to explore...
Similar Items
-
Renal Transplantation in Patients With Tuberculosis: A Single-center Experience From an Endemic Region
by: Ashwini B. Gadde, MD, DNB, et al.
Published: (2023-11-01) -
Prognostic significance of Troponin I in patients undergoing primary percutaneous coronary intervention
by: Pratik Sudhir Sane, DNB, et al.
Published: (2021-11-01) -
Effect of diabetes mellitus on markers of left ventricular dysfunction in chronic kidney disease
by: Michelle Viegas, MD.DNB.DM, et al.
Published: (2021-09-01) -
High-resolution manometry–guided endoscopic myotomy in a case with jackhammer esophagus
by: Zaheer Nabi, MD, DNB, et al.
Published: (2020-12-01) -
High-rate episodes with simultaneous atrial and ventricular activation in a patient with permanent pacemaker implantation for complete heart block
by: Saurabh Ajit Deshpande, MD, DNB, DM (Cardiology), et al.
Published: (2020-02-01)